Search results for: 'responsive artificial intelligence'

As the industry continues its innovation spree across novel small and large molecule therapies, such as RNA targeted small molecules, cell and gene therapies (CGT), and mRNA therapies, it is imperative for pharma sponsors to pursue partnerships to gain technology access, database generation and analysis, and pre-clinical and clinical research. Furt...

This report looks at global trends set to make an impact in 2020. Every year Frost & Sullivan's Visionary Innovation Team of futurists, consultants, and analysts scans the short-term horizon and looks across industries to identify areas of disruption in the new year. Along with the top trends, the study also analyzes key growth opportunities with t...